Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Isaka

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Annals of Thoracic Surgery|August 25, 2016
Epidermal Growth Factor Receptor Mutations and Prognosis in Pathologic N1-N2 Pulmonary AdenocarcinomaTetsuya Isaka, Haruhiko Nakayama, Tomoyuki Yokose, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 11, 2024
Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (≤2 cm) non-small-cell lung cancerHiroyuki Adachi, Hiroyuki Ito, Takuya Nagashima, et al.
Translational Lung Cancer Research|November 29, 2023
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1-N2 epidermal growth factor receptor mutant lung adenocarcinomaTetsuya Isaka, Yohei Miyagi, Tomoyuki Yokose, et al.
Thoracic Cancer|January 10, 2024
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma"Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, et al.
Translational Lung Cancer Research|July 11, 2026
Atypical type D extended sleeve resection after neoadjuvant chemoimmunotherapy in a 69-year-old man with locally advanced lung cancer and a tracheobronchial branching anomaly: a case reportChiaki Kanno, Takuya Nagashima, Yui Kaburaki, et al.
Translational Lung Cancer Research|August 13, 2025
Prognostic implications of MDM2 expression in surgically resected epidermal growth factor receptor mutant lung cancer with pathological lymph node metastasisTetsuya Isaka, Yohei Miyagi, Rika Kasajima, et al.
Japanese Journal of Clinical Oncology|August 20, 2024
Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and futureShun-Ichi Watanabe, Masaya Yotsukura, Tomohiro Miyoshi, et al.
Frontiers in Oncology|September 13, 2023
Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25Tetsuya Isaka, Takuya Nagashima, Hiroyuki Adachi, et al.
Thoracic Cancer|May 3, 2024
Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancerNaoko Shigeta, Shuji Murakami, Tomoyuki Yokose, et al.
Asia-Pacific Journal of Clinical Oncology|June 29, 2016
Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinomaTeppei Nishii, Tomoyuki Yokose, Yohei Miyagi, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Annals of Thoracic Surgery|August 25, 2016
Epidermal Growth Factor Receptor Mutations and Prognosis in Pathologic N1-N2 Pulmonary AdenocarcinomaTetsuya Isaka, Haruhiko Nakayama, Tomoyuki Yokose, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 11, 2024
Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (≤2 cm) non-small-cell lung cancerHiroyuki Adachi, Hiroyuki Ito, Takuya Nagashima, et al.
Translational Lung Cancer Research|November 29, 2023
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1-N2 epidermal growth factor receptor mutant lung adenocarcinomaTetsuya Isaka, Yohei Miyagi, Tomoyuki Yokose, et al.
Thoracic Cancer|January 10, 2024
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma"Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, et al.
Translational Lung Cancer Research|July 11, 2026
Atypical type D extended sleeve resection after neoadjuvant chemoimmunotherapy in a 69-year-old man with locally advanced lung cancer and a tracheobronchial branching anomaly: a case reportChiaki Kanno, Takuya Nagashima, Yui Kaburaki, et al.
Translational Lung Cancer Research|August 13, 2025
Prognostic implications of MDM2 expression in surgically resected epidermal growth factor receptor mutant lung cancer with pathological lymph node metastasisTetsuya Isaka, Yohei Miyagi, Rika Kasajima, et al.
Japanese Journal of Clinical Oncology|August 20, 2024
Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and futureShun-Ichi Watanabe, Masaya Yotsukura, Tomohiro Miyoshi, et al.
Frontiers in Oncology|September 13, 2023
Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25Tetsuya Isaka, Takuya Nagashima, Hiroyuki Adachi, et al.
Thoracic Cancer|May 3, 2024
Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancerNaoko Shigeta, Shuji Murakami, Tomoyuki Yokose, et al.
Asia-Pacific Journal of Clinical Oncology|June 29, 2016
Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinomaTeppei Nishii, Tomoyuki Yokose, Yohei Miyagi, et al.
Pageof 6